Literature DB >> 12358627

Short communication: a cluster of Marburg virus disease involving an infant.

Matthias Borchert1, Jean Jacques Muyembe-Tamfum, Robert Colebunders, Modeste Libande, Mulangu Sabue, Patrick Van Der Stuyft.   

Abstract

A noteworthy cluster of six cases of Marburg haemorrhagic fever (MHF) was identified in the Democratic Republic of Congo. One of the cases is the first infant Marburg fever patient ever documented. Three of six cases presented surprisingly mild symptoms. The results of epidemiological and virological investigations are compatible with person-to-person transmission through body fluids and with mother-to-child transmission while nurturing. The findings show that mild cases of MHF have to be expected during an outbreak and point out the difficulty to base patient management decisions on clinical case definitions alone.

Entities:  

Mesh:

Year:  2002        PMID: 12358627     DOI: 10.1046/j.1365-3156.2002.00945.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  17 in total

1.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

2.  Ebola: Hidden reservoirs.

Authors:  Jonathan L Heeney
Journal:  Nature       Date:  2015-11-26       Impact factor: 49.962

3.  Multivesicular bodies as a platform for formation of the Marburg virus envelope.

Authors:  Larissa Kolesnikova; Beate Berghöfer; Sandra Bamberg; Stephan Becker
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

4.  Factors associated with Marburg hemorrhagic fever: analysis of patient data from Uige, Angola.

Authors:  Paul Roddy; Sara L Thomas; Benjamin Jeffs; Pascoal Nascimento Folo; Pedro Pablo Palma; Bengi Moco Henrique; Luis Villa; Fernando Paixao Damiao Machado; Oscar Bernal; Steven M Jones; James E Strong; Heinz Feldmann; Matthias Borchert
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

Review 5.  A Comparison of the Pathogenesis of Marburg Virus Disease in Humans and Nonhuman Primates and Evaluation of the Suitability of These Animal Models for Predicting Clinical Efficacy under the 'Animal Rule'.

Authors:  Elizabeth R Glaze; Michael J Roy; Lonnie W Dalrymple; Lynda L Lanning
Journal:  Comp Med       Date:  2015-06       Impact factor: 0.982

Review 6.  A Forgotten Episode of Marburg Virus Disease: Belgrade, Yugoslavia, 1967.

Authors:  Elizabeta S Ristanović; Nenad S Kokoškov; Ian Crozier; Jens H Kuhn; Ana S Gligić
Journal:  Microbiol Mol Biol Rev       Date:  2020-05-13       Impact factor: 11.056

7.  New Insights Into Marburg Virus Disease Pathogenesis in the Rhesus Macaque Model.

Authors:  Timothy K Cooper; Jennifer Sword; Joshua C Johnson; Amanda Bonilla; Randy Hart; David X Liu; John G Bernbaum; Kurt Cooper; Peter B Jahrling; Lisa E Hensley
Journal:  J Infect Dis       Date:  2018-11-22       Impact factor: 5.226

8.  Electron tomography reveals the steps in filovirus budding.

Authors:  Sonja Welsch; Larissa Kolesnikova; Verena Krähling; James D Riches; Stephan Becker; John A G Briggs
Journal:  PLoS Pathog       Date:  2010-04-29       Impact factor: 6.823

9.  Response to imported case of Marburg hemorrhagic fever, the Netherland.

Authors:  Aura Timen; Marion P G Koopmans; Ann C T M Vossen; Gerard J J van Doornum; Stephan Günther; Franchette van den Berkmortel; Kees M Verduin; Sabine Dittrich; Petra Emmerich; Albert D M E Osterhaus; Jaap T van Dissel; Roel A Coutinho
Journal:  Emerg Infect Dis       Date:  2009-08       Impact factor: 6.883

10.  Clinical manifestations and case management of Ebola haemorrhagic fever caused by a newly identified virus strain, Bundibugyo, Uganda, 2007-2008.

Authors:  Paul Roddy; Natasha Howard; Maria D Van Kerkhove; Julius Lutwama; Joseph Wamala; Zabulon Yoti; Robert Colebunders; Pedro Pablo Palma; Esther Sterk; Benjamin Jeffs; Michel Van Herp; Matthias Borchert
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.